Printer Friendly

United States : LAUNCH of Donepezil Hydrochloride declared by Dr. Reddys.

After the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Donepezil Hydrochloride Tablets, 23 mg, the Dr. Reddy's Laboratories (NYSE: RDY) has introduced Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ARICEPTA, 23 mg in the US market on July 27, 2013.

As per the IMS Health the ARICEPTA, 23 mg brand had U.S. sales of about $92.6 Million MAT for the most latest twelve months ending in May 2013.

Dr. Reddy's Donepezil Hydrochloride Tablets, 23 mg is obtainable in bottle count sizes of 30 and 90.

2013 Al Bawaba (Albawaba.com)

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2013 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Aug 19, 2013
Words:111
Previous Article:United States : US FDA approves GLENMARK'S Acamprosate Calcium Delayed Release Tablets.
Next Article:United States : WESTMEAD HOSPITAL gets largest slice of Federal Labor s investment into medical treatment FACILITIES.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters